If hepatic dysfunction or elevation of ALT suggestive of hepatitis were to develop during treatment, we planned to perform additional investigations, including HBV DNA and highly sensitive HBs antigen assays, to evaluate for HBV reactivation. The gene discussed is GPT; the disease is hepatitis A virus infection.